Journal
TRENDS IN NEUROSCIENCES
Volume 36, Issue 2, Pages 133-140Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2012.12.001
Keywords
satiety; monoamines; weight loss drug
Categories
Funding
- European Union
- TI pharma and NeuroBasic
Ask authors/readers for more resources
Regulation of body weight is organized by distributed brain circuits that use a variety of neuropeptides and transmitters, and that are responsive to endocrine and metabolic signals. Targeting of these circuits with novel pharmaceutical drugs would be helpful additions to lifestyle interventions for the treatment of obesity. The recent FDA approval of two anti-obesity drugs holds promise in a field in which previous drugs were removed from clinical use because of unacceptable psychiatric and cardiovascular side effects. Here, the modes of action of anti-obesity drugs are reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available